Medicamen Organics Share Price Today

Medicamen Organics raises ₹13.65 crore via preferential allotment

Medicamen Organics Limited completed a preferential allotment of 27,14,285 equity shares and 11,85,715 warrants on June 09, 2026, raising an aggregate issue size of ₹13.65 crore. The securities were allotted to promoter Bal Kishan Gupta and non-promoter Pradeep Kumar Jain at an issue price of ₹35 each, increasing the paid-up share capital to ₹14.88 crore. The allotment includes the conversion of an existing loan into equity shares, with the remaining consideration for warrants to be received within 18 months.

Medicamen Organics promoter group confirms no encumbrance on FY26 shares

Medicamen Organics Limited promoter group members Bal Kishan Gupta, Ashutosh Gupta, and Ishaan Gupta declared that no encumbrance was created or invoked on their equity shares during FY26, complying with SEBI Takeover Regulations.

Medicamen Organics reports FY26 net loss of ₹401.94 lakh

Medicamen Organics Limited reported a consolidated net loss of ₹401.94 lakh for FY26 against a profit of ₹404.71 lakh in FY25, with revenue falling to ₹2270.91 lakh. The auditors noted unprovided legal and tax liabilities, and the company wrote off ₹110 lakh in receivables from a subsidiary. Shareholders approved a variation in IPO objects, reallocating ₹162.44 lakh to working capital.

Medicamen Organics amends fair disclosure code on May 29

Medicamen Organics Limited approved an amended Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI) on May 29, 2026. The code, effective immediately, mandates a framework for fair disclosure, designates the Company Secretary as the Chief Investor Relations Officer, and requires the maintenance of a Structured Digital Database for UPSI records.

Medicamen Organics shares valuation report for EGM

Medicamen Organics disclosed a valuation report by M/s Jhamb & Associates for its EGM on May 23, 2026. The report complies with SEBI (ICDR) Regulations, 2018, and is available on the company website.

Medicamen Organics Expands into Beauty and Personal Care Sector

Medicamen Organics, a pharmaceutical company, has announced its entry into the beauty and personal care sector. This strategic move marks a significant diversification of the company's business portfolio. While specific details about the new product line and launch timeline are yet to be disclosed, this expansion could open up new revenue streams and market opportunities for the company. The move may allow Medicamen Organics to tap into the growing beauty market, potentially leveraging synergies between its pharmaceutical expertise and personal care product development.